HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

Nature Biotechnology
Germán G GornalusseDavid W Russell

Abstract

Polymorphisms in the human leukocyte antigen (HLA) class I genes can cause the rejection of pluripotent stem cell (PSC)-derived products in allogeneic recipients. Disruption of the Beta-2 Microglobulin (B2M) gene eliminates surface expression of all class I molecules, but leaves the cells vulnerable to lysis by natural killer (NK) cells. Here we show that this 'missing-self' response can be prevented by forced expression of minimally polymorphic HLA-E molecules. We use adeno-associated virus (AAV)-mediated gene editing to knock in HLA-E genes at the B2M locus in human PSCs in a manner that confers inducible, regulated, surface expression of HLA-E single-chain dimers (fused to B2M) or trimers (fused to B2M and a peptide antigen), without surface expression of HLA-A, B or C. These HLA-engineered PSCs and their differentiated derivatives are not recognized as allogeneic by CD8(+) T cells, do not bind anti-HLA antibodies and are resistant to NK-mediated lysis. Our approach provides a potential source of universal donor cells for applications where the differentiated derivatives lack HLA class II expression.

References

Feb 1, 1992·Current Opinion in Immunology·T J Braciale
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K SpriggsC R Maliszewski
Feb 17, 1997·The Journal of Experimental Medicine·A G BrooksJ E Coligan
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·F ZappacostaJ E Coligan
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·N Rouas-FreissE D Carosella
Mar 5, 1998·Nature·V M BraudA J McMichael
Apr 16, 1998·Nature Genetics·D W Russell, R K Hirata
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·N LeeD E Geraghty
Nov 6, 1998·Science·J A ThomsonJ M Jones
Aug 10, 2000·Clinical and Experimental Immunology·S D GadolaV Cerundolo
Jul 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joseph D MillerPeter E Jensen
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gabriella PietraMaria Cristina Mingari
Dec 5, 1964·Nature·P I TERASAKI, J D MCCLELLAND
Feb 21, 2004·Science·Joel R ChamberlainDavid W Russell
Mar 10, 2004·The Journal of Experimental Medicine·Shayna E A StreetMark J Smyth
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yiming HuangSuzanne T Ildstad
Aug 14, 2008·Nature Reviews. Molecular Cell Biology·Shin-ichi NishikawaConcepcion R Nierras
Mar 14, 2009·Trends in Immunology·Petter BrodinPetter Höglund
Oct 8, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Amir S KhanMarta L Fiorotto
Apr 22, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Iram F KhanDavid W Russell
Jun 23, 2010·Immunology and Cell Biology·Hollie J PegramMichael H Kershaw
Jul 17, 2010·Journal of Biomedicine & Biotechnology·Gabriella PietraMaria Cristina Mingari
Apr 2, 2011·Nature Protocols·Iram F KhanDavid W Russell
Jun 6, 2012·Methods in Molecular Biology·Nina LauterbachMarcel G J Tilanus
Oct 23, 2012·Cell Stem Cell·Li B LiDavid W Russell
May 1, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Laura RiolobosDavid W Russell
Jun 13, 2013·Methods in Molecular Biology·Naoki Ichiryu, Paul J Fairchild
Sep 3, 2013·Methods in Molecular Biology·Rebecca J Aicheler, Richard J Stanton
Oct 25, 2013·Science Translational Medicine·Amir HorowitzCatherine A Blish
Mar 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Carol B WareHannele Ruohola-Baker
Jan 22, 2015·Investigative Ophthalmology & Visual Science·Lyndsay L LeachDennis O Clegg
Aug 20, 2015·Stem Cells Translational Medicine·Dachun WangRick A Wetsel

❮ Previous
Next ❯

Citations

Aug 9, 2017·Nature Biotechnology·Steven C Kim, Andrew B Adams
Nov 17, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marco Ruella, Saad S Kenderian
Jan 10, 2018·Frontiers in Medicine·Ulrich Martin
Jan 19, 2018·Annual Review of Biomedical Engineering·Matthew J BrennerWilson W Wong
Aug 1, 2018·Current Opinion in Organ Transplantation·Antoine SicardMegan K Levings
Oct 14, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Yang LinMervin C Yoder
Nov 30, 2018·Cancer Science·Shoichi Iriguchi, Shin Kaneko
Oct 27, 2018·Seminars in Immunopathology·Michelle L SaetersmoenKarl-Johan Malmberg
Nov 30, 2018·Transplantation·Anusha Shweta ShankarMartin J Hoogduijn
Jan 12, 2019·American Journal of Hematology·Waseem Qasim
Mar 15, 2019·Circulation Research·Thomas Eschenhagen, Florian Weinberger
Mar 13, 2019·The Journal of Clinical Investigation·Takahiro KamiyaDario Campana
May 2, 2019·Proceedings of the National Academy of Sciences of the United States of America·Xiao HanChad A Cowan
Nov 7, 2019·Journal of Cellular Physiology·Alireza MardomiSaeid Abediankenari
Dec 12, 2019·Journal of Tissue Engineering and Regenerative Medicine·Claudia BilodeauMartin Post
Jan 18, 2020·Briefings in Functional Genomics·Chenggong LiYu Hu
Dec 8, 2019·Nature Reviews. Immunology·Caroline RaffinJeffrey A Bluestone
Jan 5, 2020·Nature Reviews. Drug Discovery·S DepilL Poirot
May 1, 2020·Cytometry. Part B, Clinical Cytometry·Elena MaryamchikMarcela V Maus
Dec 7, 2019·Cellular and Molecular Life Sciences : CMLS·Marije KoningTon J Rabelink
Jun 26, 2020·Stem Cells Translational Medicine·Lisa C KadykSohel Talib
Jun 27, 2020·Current Protocols in Stem Cell Biology·Jack Hermsen, Matthew E Brown
Jul 30, 2020·Stem Cells Translational Medicine·Selami DemirciJohn F Tisdale
Sep 27, 2019·Nature Communications·Romina Aron BadinAnselme L Perrier
Mar 24, 2018·Science·Carl H JuneMichael C Milone
Oct 12, 2018·Physiology·Rangarajan SambathkumarMaria Cristina Nostro
May 6, 2019·Cells·Michael Xavier Doss, Agapios Sachinidis
Apr 24, 2019·Nature Biomedical Engineering·Louai LabaniehCrystal L Mackall
Jun 14, 2019·Stem Cells International·Methichit Wattanapanitch
Jan 8, 2020·Nature Reviews. Drug Discovery·Noriko ShimasakiDario Campana
Mar 7, 2020·Frontiers in Immunology·Cai ZhangChongdeng Shi
May 28, 2020·Nature·Lorenz Studer, Viviane Tabar
Jul 15, 2020·Nature Biotechnology·Feiyan MoMaksim Mamonkin
Jun 9, 2020·British Journal of Haematology·Olivier HumbertHans-Peter Kiem

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
dispase
apheresis

Software Mentioned

FlowJo
GraphPad Prism
Living Image
Image J

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.